Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients

BACKGROUND: In the past, multiple sclerosis (MS) medications have been primarily designed to modulate T cell properties. Based on the emerging concept that B cells are equally important for the propagation of MS, we compared the effect of four commonly used, primarily T cell-targeting MS medications...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Neuroinflammation
Päätekijät: Traub, Jan W., Pellkofer, Hannah L., Grondey, Katja, Seeger, Ira, Rowold, Christoph, Brück, Wolfgang, Husseini, Leila, Häusser-Kinzel, Silke, Weber, Martin S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858649/
https://ncbi.nlm.nih.gov/pubmed/31733652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-019-1593-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia